World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02437721
Date of registration: 30/03/2015
Prospective Registration: Yes
Primary sponsor: DSM Nutritional Products, Inc.
Public title: Suitability of an Infant Formula With L-5-Methyltetrahydrofolate for the Particular Nutritional Use in Infants MEFOLIN
Scientific title: Suitability of an Infant Formula With L-5-Methyltetrahydrofolate for the Particular Nutritional Use in Infants
Date of first enrolment: May 2015
Target sample size: 360
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02437721
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Serbia
Contacts
Name:     Berthold Koletzko, Prof.
Address: 
Telephone:
Email:
Affiliation:  Ludwig-Maximilians - University of Munich
Key inclusion & exclusion criteria

Inclusion Criteria:

- Written informed consent (by parents, caregiver)

- Healthy male or female infants <28 days of life

- Gestational age at delivery =37 and =42 weeks

- Birth weight between 2500 - 4500g

- Parents / Caregivers are able to speak Serbian language

Exclusion Criteria:

- Serious acquired or congenital diseases that is expected to interfere with normal
feeding or growth

- Feeding of more than 10% of energy (1 bottle/day) from sources other than the formula
(or breast milk in the reference group) at inclusion

- Participation in another clinical study

- Mothers with diabetes mellitus (including gestational diabetes)

- Reason to presume that the parents are unable to meet the study plan requirements

- Diseases of the mother which have an effect on the child's gastro-intestinal
tract/ability to be fed

- Major abnormalities in hematological parameters

- Major abnormalities in hepatic, renal or metabolic functions

- Use of medication and vitamin supplements except vitamin K or D supplementation or
vaccination

- Mother follows a vegan diet



Age minimum: N/A
Age maximum: 27 Days
Gender: All
Health Condition(s) or Problem(s) studied
Growth and Development
Intervention(s)
Other: infant formula containing folic acid
Other: infant formula containing MTHF
Primary Outcome(s)
weight gain (gram/day) [Time Frame: age of 4 weeks until age of 16 weeks]
Secondary Outcome(s)
fronto-occipital head circumference gain (in cm/day) [Time Frame: at age of 4 weeks and at the age of 16 weeks]
body length gain (cm/day) [Time Frame: age of 4 weeks until age of 16 weeks]
stool characteristics (color and consistency) [Time Frame: during the period age 4 weeks to age 16 weeks]
dietary intake of study formula, non-study formula, additional liquids and solids [Time Frame: during the period age 4 weeks to age 16 weeks]
feeding related behavior questionnaire [Time Frame: during the period age 4 weeks to age 16 weeks]
Secondary ID(s)
2014-05-06-MTHF
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Institute for Laboratory Diagnostics Konzilijum
Bevital AS
Sermon CRO
Charite University, Berlin, Germany
Ludwig-Maximilians - University of Munich
HiPP GmbH & Co. Vertrieb KG
University Clinic Dr Dragisa Misovic-Dedinje
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history